Search Results

You searched for: cabazitaxel

SMC Advice

  • cabazitaxel (Jevtana)
    SMC Drug ID: 735/11; Manufacturer: Sanofi-Aventis; Indication: In combination with prednisone or prednisolone, cabazitaxel is licensed for the treatment of patients with hormone refractory metastatic prostate cancer previously treated with a docetaxel-containing regimen. ; Submission Type: Full submission; Status: Not Recommended; Date Advice Published:  07/11/2011;
  • Briefing note: cabazitaxel (Jevtana)

About SMC

  • SMC Minutes - Tuesday 04 October 2011
    Minutes of the SMC Meeting held on Tuesday 04 October 2011 Healthcare Improvement Scotland, Delta House, 50 West Nile Street, Glasgow, G1 2NP Present: Ms Angela Timoney (Chairman), Ms Sandra Auld, Dr ...
  • SMC Minutes Tuesday 01 November 2011
    Minutes of the SMC Meeting held on Tuesday 01 November 2011 Healthcare Improvement Scotland, Delta House, 50 West Nile Street, Glasgow, G1 2NP Present: Ms Angela Timoney (Chairman), Mrs Laura Ace, Ms ...

Help on how to improve your search.